Macrogenics (MGNX)

$1.37 -0.01 (-0.72%)
Market Cap 87.30M
Revenue (ttm) 149.96M
Net Income (ttm) -66.97M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -44.66%
Debt to Equity Ratio 0.00
Volume 5,122,900
Avg Vol 804,140
Day's Range N/A - N/A
Shares Out 63.26M
Stochastic %K 32%
Beta 1.52
Analysts Sell
Price Target $3.40

Company Profile

MacroGenics, Inc., a clinical-stage biopharmaceutical company, discovers, develops, manufactures, and commercializes antibody-based therapeutics to treat cancer in the United States. The company's product pipeline includes lorigerlimab, a bispecific DART molecule that targets checkpoint inhibitors PD-1 and CTLA-4 for the treatment of mCRPC and docetaxel that is in phase 2 clinical trials, as well as for the treatment of platinum-resistant ovarian cancer and clear cell gynecologic cancer which ha...

Industry: Biotechnology
Sector: Healthcare
Phone: 301 251 5172
Fax: 301 251 5321
Address:
9704 Medical Center Drive, Rockville, United States
Budman10
Budman10 Dec. 5 at 10:09 PM
$MGNX If Management had one single ounce of care for the shareholders they would announce the share buyback. Maybe when we hit the next support level at $1.22 they will. I doubt it as they want to use the cash to pay themselves a salary for the next 2 years.
0 · Reply
Budman10
Budman10 Dec. 5 at 8:45 PM
$MGNX I told you below
0 · Reply
PMD777
PMD777 Dec. 5 at 8:21 PM
$MGNX there has been 3 separate 500k purchases alone today.. what is happening?
0 · Reply
MarketWarfare
MarketWarfare Dec. 5 at 6:18 PM
$MGNX very heavy 3.4 million volume and counting. Stayed green for a total of 20 minutes. The crooks have this stock under complete control knowing the CEO and management are useless turds.
0 · Reply
Budman10
Budman10 Dec. 5 at 6:17 PM
$MGNX Short interest (3.6 million) has remained the same this past month and has come down about 1.5 million shares since the beginning of the year so it would appear the shorts don’t want to mess with it. Currently, 73% is held by the institutions and 3% by inept management. The recent increase in volume along with falling share price may indicate a fund is selling off right now for a tax loss. There is a somewhat controlled decline in price Meaning still some support out there. That may explain what you are seeing PSDL75.
0 · Reply
PSDL75
PSDL75 Dec. 5 at 6:00 PM
$MGNX more of the same
0 · Reply
Drugtrade
Drugtrade Dec. 5 at 6:00 PM
$MGNX bought more todays dip 🫳🍿
0 · Reply
PSDL75
PSDL75 Dec. 5 at 5:01 PM
$CRDF $MGNX I own both these turds and you can tell that MM stick a big chunk of shares on the ask to keep it in place and then slowly move them down. Sucks they're both getting the same treatment and trading pattern.
0 · Reply
Budman10
Budman10 Dec. 5 at 1:27 PM
$MGNX Just a piggy bank for inept management‘s salary.
0 · Reply
PSDL75
PSDL75 Dec. 4 at 9:29 PM
$MGNX nothing exciting to report, but looks like that wedge will move us down to the $1.30 support or a double bottom below that. $2.16 ish is resistance. Hopefully we break out with a Santa rally and a life line
0 · Reply
Latest News on MGNX
MacroGenics to Participate in the 8th Annual Evercore Healthcare Conference

Nov 25, 2025, 4:05 PM EST - 10 days ago

MacroGenics to Participate in the 8th Annual Evercore Healthcare Conference

MacroGenics Reports Third Quarter 2025 Financial Results and Provides Update on Corporate Progress

Nov 12, 2025, 4:01 PM EST - 23 days ago

MacroGenics Reports Third Quarter 2025 Financial Results and Provides Update on Corporate Progress

MacroGenics to Participate in the Stifel 2025 Healthcare Conference

Nov 6, 2025, 4:30 PM EST - 4 weeks ago

MacroGenics to Participate in the Stifel 2025 Healthcare Conference

MacroGenics to Present at H.C. Wainwright 27th Annual Global Investment Conference

Sep 2, 2025, 4:30 PM EDT - 3 months ago

MacroGenics to Present at H.C. Wainwright 27th Annual Global Investment Conference

MacroGenics Reports Second Quarter 2025 Financial Results and Highlights Key Strategic Priorities

Aug 14, 2025, 4:01 PM EDT - 4 months ago

MacroGenics Reports Second Quarter 2025 Financial Results and Highlights Key Strategic Priorities

MacroGenics Appoints Eric Risser as President and Chief Executive Officer

Aug 13, 2025, 4:01 PM EDT - 4 months ago

MacroGenics Appoints Eric Risser as President and Chief Executive Officer

MacroGenics: Working On That Road To Recovery

Jun 11, 2025, 6:32 PM EDT - 6 months ago

MacroGenics: Working On That Road To Recovery

MacroGenics and Sagard Healthcare Partners Enter into ZYNYZ® Royalty Purchase Agreement

Jun 10, 2025, 7:00 AM EDT - 6 months ago

MacroGenics and Sagard Healthcare Partners Enter into ZYNYZ® Royalty Purchase Agreement

MacroGenics to Present at the Goldman Sachs 46th Annual Global Healthcare Conference 2025

Jun 3, 2025, 4:30 PM EDT - 6 months ago

MacroGenics to Present at the Goldman Sachs 46th Annual Global Healthcare Conference 2025

MacroGenics Provides Update on Corporate Progress and First Quarter 2025 Financial Results

May 13, 2025, 4:01 PM EDT - 7 months ago

MacroGenics Provides Update on Corporate Progress and First Quarter 2025 Financial Results

MacroGenics Announces Date of First Quarter 2025 Financial Results

May 6, 2025, 4:30 PM EDT - 7 months ago

MacroGenics Announces Date of First Quarter 2025 Financial Results

MacroGenics to Participate in Upcoming Investor Conference

May 1, 2025, 4:30 PM EDT - 7 months ago

MacroGenics to Participate in Upcoming Investor Conference

MacroGenics, Inc. (MGNX) Q4 2024 Earnings Call Transcript

Mar 20, 2025, 7:09 PM EDT - 9 months ago

MacroGenics, Inc. (MGNX) Q4 2024 Earnings Call Transcript

MacroGenics Announces Date of Fourth Quarter and Full Year 2024 Financial Results Conference Call

Mar 6, 2025, 7:30 AM EST - 9 months ago

MacroGenics Announces Date of Fourth Quarter and Full Year 2024 Financial Results Conference Call

MacroGenics: Stacking Up A Lot Of Headwinds

Feb 27, 2025, 2:08 PM EST - 10 months ago

MacroGenics: Stacking Up A Lot Of Headwinds

MacroGenics to Participate in Upcoming Investor Conferences

Feb 27, 2025, 7:30 AM EST - 10 months ago

MacroGenics to Participate in Upcoming Investor Conferences

MacroGenics, Inc. (MGNX) Q2 2024 Earnings Call Transcript

Nov 5, 2024, 7:01 PM EST - 1 year ago

MacroGenics, Inc. (MGNX) Q2 2024 Earnings Call Transcript

MacroGenics Provides Update on Corporate Progress, Third Quarter 2024 Financial Results

Nov 5, 2024, 4:01 PM EST - 1 year ago

MacroGenics Provides Update on Corporate Progress, Third Quarter 2024 Financial Results

MacroGenics Announces Leadership Transition

Oct 30, 2024, 7:30 AM EDT - 1 year ago

MacroGenics Announces Leadership Transition

MacroGenics Announces Date of Third Quarter 2024 Financial Results Conference Call

Oct 29, 2024, 4:30 PM EDT - 1 year ago

MacroGenics Announces Date of Third Quarter 2024 Financial Results Conference Call

Rigrodsky Law, P.A. Is Investigating MacroGenics, Inc. On Behalf of Shareholders

Oct 25, 2024, 5:15 PM EDT - 1 year ago

Rigrodsky Law, P.A. Is Investigating MacroGenics, Inc. On Behalf of Shareholders

MacroGenics Enters Into Agreement With TerSera Therapeutics for the Sale of MARGENZA®

Oct 22, 2024, 7:30 AM EDT - 1 year ago

MacroGenics Enters Into Agreement With TerSera Therapeutics for the Sale of MARGENZA®

Shareholders of MacroGenics, Inc. Should Contact The Gross Law Firm Before September 24, 2024 to Discuss Your Rights – MGNX

Sep 24, 2024, 12:57 PM EDT - 1 year ago

Shareholders of MacroGenics, Inc. Should Contact The Gross Law Firm Before September 24, 2024 to Discuss Your Rights – MGNX

MGNX Investors Have Opportunity to Join MacroGenics, Inc. Fraud Investigation with the Schall Law Firm

Sep 24, 2024, 10:30 AM EDT - 1 year ago

MGNX Investors Have Opportunity to Join MacroGenics, Inc. Fraud Investigation with the Schall Law Firm

MacroGenics Inc Is Being Sued For Violating Securities Laws And Shareholders With Losses Are Encouraged To Contact The Schall Law Firm

Sep 23, 2024, 11:00 AM EDT - 1 year ago

MacroGenics Inc Is Being Sued For Violating Securities Laws And Shareholders With Losses Are Encouraged To Contact The Schall Law Firm

MacroGenics (MGNX) Accused of Misleading Investors Over Cancer Drug Trial - Hagens Berman

Sep 22, 2024, 11:09 AM EDT - 1 year ago

MacroGenics (MGNX) Accused of Misleading Investors Over Cancer Drug Trial - Hagens Berman

MacroGenics Inc Is Being Sued For Violating Securities Laws And Shareholders With Losses Are Urged To Reach Out To The Schall Law Firm

Sep 21, 2024, 11:00 AM EDT - 1 year ago

MacroGenics Inc Is Being Sued For Violating Securities Laws And Shareholders With Losses Are Urged To Reach Out To The Schall Law Firm

MacroGenics Inc Is Being Sued For Violating Securities Laws And Shareholders Are Urged To Contact The Schall Law Firm

Sep 19, 2024, 11:00 AM EDT - 1 year ago

MacroGenics Inc Is Being Sued For Violating Securities Laws And Shareholders Are Urged To Contact The Schall Law Firm

DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of MacroGenics

Sep 19, 2024, 9:57 AM EDT - 1 year ago

DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of MacroGenics

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of September 24, 2024 in MacroGenics Lawsuit - MGNX

Sep 19, 2024, 5:45 AM EDT - 1 year ago

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of September 24, 2024 in MacroGenics Lawsuit - MGNX

MGNX Deadline: Rosen Law Firm Urges MacroGenics, Inc. (NASDAQ: MGNX) Stockholders with Large Losses in Excess of $100K to Contact the Firm for Information About Their Rights

Sep 17, 2024, 11:23 AM EDT - 1 year ago

MGNX Deadline: Rosen Law Firm Urges MacroGenics, Inc. (NASDAQ: MGNX) Stockholders with Large Losses in Excess of $100K to Contact the Firm for Information About Their Rights

Hospice Dynamix Welcomes Industry Veteran Rob Stoltz as Chief Strategy Officer

Sep 17, 2024, 11:04 AM EDT - 1 year ago

Hospice Dynamix Welcomes Industry Veteran Rob Stoltz as Chief Strategy Officer

MacroGenics Inc May Have Violated Securities Laws And Shareholders With Losses Are Urged To Contact The Schall Law Firm About A Suit

Sep 17, 2024, 11:00 AM EDT - 1 year ago

MacroGenics Inc May Have Violated Securities Laws And Shareholders With Losses Are Urged To Contact The Schall Law Firm About A Suit

Investor Reminder (MGNX):  Kessler Topaz Meltzer & Check, LLP Reminds MacroGenics, Inc.  Investors of September 24, 2024 Deadline

Sep 16, 2024, 12:14 PM EDT - 1 year ago

Investor Reminder (MGNX):  Kessler Topaz Meltzer & Check, LLP Reminds MacroGenics, Inc.  Investors of September 24, 2024 Deadline

Budman10
Budman10 Dec. 5 at 10:09 PM
$MGNX If Management had one single ounce of care for the shareholders they would announce the share buyback. Maybe when we hit the next support level at $1.22 they will. I doubt it as they want to use the cash to pay themselves a salary for the next 2 years.
0 · Reply
Budman10
Budman10 Dec. 5 at 8:45 PM
$MGNX I told you below
0 · Reply
PMD777
PMD777 Dec. 5 at 8:21 PM
$MGNX there has been 3 separate 500k purchases alone today.. what is happening?
0 · Reply
MarketWarfare
MarketWarfare Dec. 5 at 6:18 PM
$MGNX very heavy 3.4 million volume and counting. Stayed green for a total of 20 minutes. The crooks have this stock under complete control knowing the CEO and management are useless turds.
0 · Reply
Budman10
Budman10 Dec. 5 at 6:17 PM
$MGNX Short interest (3.6 million) has remained the same this past month and has come down about 1.5 million shares since the beginning of the year so it would appear the shorts don’t want to mess with it. Currently, 73% is held by the institutions and 3% by inept management. The recent increase in volume along with falling share price may indicate a fund is selling off right now for a tax loss. There is a somewhat controlled decline in price Meaning still some support out there. That may explain what you are seeing PSDL75.
0 · Reply
PSDL75
PSDL75 Dec. 5 at 6:00 PM
$MGNX more of the same
0 · Reply
Drugtrade
Drugtrade Dec. 5 at 6:00 PM
$MGNX bought more todays dip 🫳🍿
0 · Reply
PSDL75
PSDL75 Dec. 5 at 5:01 PM
$CRDF $MGNX I own both these turds and you can tell that MM stick a big chunk of shares on the ask to keep it in place and then slowly move them down. Sucks they're both getting the same treatment and trading pattern.
0 · Reply
Budman10
Budman10 Dec. 5 at 1:27 PM
$MGNX Just a piggy bank for inept management‘s salary.
0 · Reply
PSDL75
PSDL75 Dec. 4 at 9:29 PM
$MGNX nothing exciting to report, but looks like that wedge will move us down to the $1.30 support or a double bottom below that. $2.16 ish is resistance. Hopefully we break out with a Santa rally and a life line
0 · Reply
PSDL75
PSDL75 Dec. 4 at 9:16 PM
$MGNX I've seen 5M shares trade on a sub 1m a day stock... Have to assume this is planned and it will have a pent up run...I HOPE and PRAY.
0 · Reply
PSDL75
PSDL75 Dec. 4 at 9:07 PM
$MGNX literally WTH
0 · Reply
MarketWarfare
MarketWarfare Dec. 4 at 9:05 PM
$MGNX another high volume day. Someone really making sure this turd POS doesn't have even a single green day. Easy to control the stock when management doesn't give one single fuck.
0 · Reply
PSDL75
PSDL75 Dec. 4 at 6:11 PM
$MGNX Just regret every share of this piece of crap in my account. Other similar risky stocks running their face off
1 · Reply
MarketWarfare
MarketWarfare Dec. 3 at 9:11 PM
$MGNX just a random 2.1M volume day after weeks of bullshit volume. Of course another red day on a +400 Dow day.
0 · Reply
PSDL75
PSDL75 Dec. 3 at 8:09 PM
$MGNX lol...come on MM we see you
0 · Reply
PSDL75
PSDL75 Dec. 3 at 7:51 PM
$MGNX tons of volume... with an hour left we're nearly double the average
0 · Reply
PSDL75
PSDL75 Dec. 3 at 7:04 PM
$MGNX dubious on this high volume drop
1 · Reply
Rrrr007
Rrrr007 Dec. 3 at 5:25 PM
$MGNX Can we call it a P.O.S
0 · Reply
PSDL75
PSDL75 Dec. 3 at 5:17 PM
$MGNX looks like a red chart...100k bought and it didn't move?
0 · Reply
MaxProfitTrades
MaxProfitTrades Dec. 2 at 6:10 PM
$MGNX 😎 where is everybody lol
1 · Reply
MarketWarfare
MarketWarfare Dec. 1 at 7:05 PM
$MGNX hopeless turd of a company. Market soars and this pos does nothing. Any weakness and this pos drops with ease.
0 · Reply